These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32536446)

  • 1. Ketamine for neuropathic pain: a tiger that won't bite?
    Dahan A; van Velzen M; Niesters M
    Br J Anaesth; 2020 Sep; 125(3):e275-e276. PubMed ID: 32536446
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical amitriptyline and ketamine for the treatment of neuropathic pain.
    Mercadante S
    Expert Rev Neurother; 2015; 15(11):1249-53. PubMed ID: 26488799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effect of oral ketamine in chronic neuropathic pain of spinal origin: a case report.
    Fisher K; Hagen NA
    J Pain Symptom Manage; 1999 Jul; 18(1):61-6. PubMed ID: 10439575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How effective is ketamine in the management of chronic neuropathic pain?
    Shteamer JW; Callaway MA; Patel P; Singh V
    Pain Manag; 2019 Nov; 9(6):517-519. PubMed ID: 31613180
    [No Abstract]   [Full Text] [Related]  

  • 5. Ketamine: When Delirium and Desperation Call for a Hero.
    Moazam C; Hirst J; Mesarwi P; Atayee RS
    J Pain Palliat Care Pharmacother; 2019; 33(3-4):120-124. PubMed ID: 31689170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
    Elsewaisy O; Slon B; Monagle J
    Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical amitriptyline and ketamine for post-herpetic neuralgia and other forms of neuropathic pain.
    Sawynok J; Zinger C
    Expert Opin Pharmacother; 2016; 17(4):601-9. PubMed ID: 26809783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine for cancer pain: what is the evidence?
    Jonkman K; van de Donk T; Dahan A
    Curr Opin Support Palliat Care; 2017 Jun; 11(2):88-92. PubMed ID: 28306568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms and treatment of neuropathic pain.
    Vranken JH
    Cent Nerv Syst Agents Med Chem; 2009 Mar; 9(1):71-8. PubMed ID: 20021340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose ketamine in the management of cancer-related neuropathic pain.
    Tarumi Y; Watanabe S; Bruera E; Ishitani K
    J Pain Symptom Manage; 2000 Jun; 19(6):405-7. PubMed ID: 10991642
    [No Abstract]   [Full Text] [Related]  

  • 11. NMDA receptor antagonists for the treatment of neuropathic pain.
    Collins S; Sigtermans MJ; Dahan A; Zuurmond WW; Perez RS
    Pain Med; 2010 Nov; 11(11):1726-42. PubMed ID: 21044263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine for analgesia.
    Daley M; Roberts JC; Washington S
    Br J Hosp Med (Lond); 2012 Jun; 73(6):358. PubMed ID: 22875332
    [No Abstract]   [Full Text] [Related]  

  • 13. Analgesic effects of topical ketamine.
    Kopsky DJ; Keppel Hesselink JM; Bhaskar A; Hariton G; Romanenko V; Casale R
    Minerva Anestesiol; 2015 Apr; 81(4):440-9. PubMed ID: 24847738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous Ketamine as an Adjunct for Pachyonychia Congenita-Associated Pain: A Case Report.
    Paul JM; Orlovich DS; Patton JW; Qian X
    A A Pract; 2019 Oct; 13(8):319-321. PubMed ID: 31343433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Ketamine vs Placebo in Patients With Cancer-Related Neuropathic Pain: A Randomized Clinical Trial.
    Fallon MT; Wilcock A; Kelly CA; Paul J; Lewsley LA; Norrie J; Laird BJA
    JAMA Oncol; 2018 Jun; 4(6):870-872. PubMed ID: 29621378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
    Kong PE; Snijdelaar DG; Crul BJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2556-8. PubMed ID: 12532671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological issues associated with clinical trials in neuropathic pain.
    Gilron I
    Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1399-1402. PubMed ID: 27659719
    [No Abstract]   [Full Text] [Related]  

  • 19. Comment on: Serpell et al., gabapentin in neuropathic pain syndromes: a randomised double-blind, placebo controlled trial (Pain 2002; 99: 557-66).
    McCleane GJ
    Pain; 2003 May; 103(1-2):227; author reply 228. PubMed ID: 12749981
    [No Abstract]   [Full Text] [Related]  

  • 20. Ketamine for acute neuropathic pain in patients with spinal cord injury.
    Kim K; Mishina M; Kokubo R; Nakajima T; Morimoto D; Isu T; Kobayashi S; Teramoto A
    J Clin Neurosci; 2013 Jun; 20(6):804-7. PubMed ID: 23618680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.